EPA:EQS • FR0012882389
The current stock price of EQS.PA is 35.6 EUR. In the past month the price decreased by -9.82%. In the past year, price decreased by -3.5%.
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA. EQS.PA scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months EQS.PA reported a non-GAAP Earnings per Share(EPS) of 2.4. The EPS decreased by -13.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.13% | ||
| ROA | 8.82% | ||
| ROE | 15.77% | ||
| Debt/Equity | 0.09 |
6 analysts have analysed EQS.PA and the average price target is 54.06 EUR. This implies a price increase of 51.85% is expected in the next year compared to the current price of 35.6.
For the next year, analysts expect an EPS growth of 11.67% and a revenue growth 9.26% for EQS.PA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| GPI | GPI SPA | 17.55 | 507.081M | ||
| ALMDT | MEDIAN TECHNOLOGIES | N/A | 189.842M | ||
| ALCGM | CEGEDIM SA | 7.07 | 166.38M | ||
| AGFB | AGFA-GEVAERT NV | 9.59 | 74.004M | ||
| AJ91 | DOCCHECK AG | N/A | 65.403M | ||
| M3V | MEVIS MEDICAL SOLUTIONS AG | N/A | 45.864M | ||
| ALINS | INTRASENSE SAS | N/A | 13.075M | ||
| MLLAB | MEDIA LAB SPA | N/A |
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
EQUASENS
5 Allee de Saint-Cloud
Villers-les-Nancy GRAND EST FR
Employees: 1271
Phone: 33383159595
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
The current stock price of EQS.PA is 35.6 EUR. The price decreased by -0.56% in the last trading session.
EQUASENS (EQS.PA) has a dividend yield of 3.64%. The yearly dividend amount is currently 1.25.
EQS.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
EQS.PA stock is listed on the Euronext Paris exchange.
The PE ratio for EQUASENS (EQS.PA) is 14.83. This is based on the reported non-GAAP earnings per share of 2.4 and the current share price of 35.6 EUR.
EQUASENS (EQS.PA) has a market capitalization of 540.05M EUR. This makes EQS.PA a Small Cap stock.